Search Results

There are 6001 results for: content related to: Unexpected Low-Temperature Behaviour of Piroxicam Monohydrate

  1. You have free access to this content
    Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 367–377, Igor E. Shohin, Julia I. Kulinich, Galina V. Ramenskaya, Bertil Abrahamsson, Sabine Kopp, Peter Langguth, James E. Polli, Vinod P. Shah, D. W. Groot, Dirk M. Barends and Jennifer B. Dressman

    Version of Record online : 2 DEC 2013, DOI: 10.1002/jps.23799

  2. Single dose oral piroxicam for acute postoperative pain

    Intervention Review

    The Cochrane Library

    R Andrew Moore, Jayne Edwards, Yoon Loke, Sheena Derry and Henry J McQuay

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002762

  3. Influence of environment on piroxicam polymorphism: Vibrational spectroscopic study

    Biopolymers

    Volume 62, Issue 1, 2001, Pages: 68–78, Paola Taddei, Armida Torreggiani and Rosa Simoni

    Version of Record online : 15 DEC 2000, DOI: 10.1002/1097-0282(2001)62:1<68::AID-BIP80>3.0.CO;2-X

  4. Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria

    Inflammatory Bowel Diseases

    Volume 11, Issue 12, December 2005, Pages: 1060–1069, Laura P Hale, Marcia R Gottfried and Alexander Swidsinski

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000187582.90423.bc

  5. Melatonin protects against piroxicam-induced gastric ulceration

    Journal of Pineal Research

    Volume 36, Issue 3, April 2004, Pages: 195–203, Debashis Bandyopadhyay, Goutam Ghosh, Arun Bandyopadhyay and Russel J. Reiter

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1600-079X.2004.00118.x

  6. 14N Nuclear Quadrupole Resonance Study of Piroxicam: Confirmation of New Polymorphic Form V

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 6, June 2015, Pages: 1909–1918, Zoran Lavrič, Janez Pirnat, Janko Lužnik, Uroš Puc, Zvonko Trontelj and Stane Srčič

    Version of Record online : 16 MAR 2015, DOI: 10.1002/jps.24421

  7. You have free access to this content
    Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1

    International Journal of Cancer

    Volume 107, Issue 5, 10 December 2003, Pages: 830–836, Haiming Ding, Chunhua Han, Ruth Gibson-D′Ambrosio, Vernon E. Steele and Steven M. D′Ambrosio

    Version of Record online : 12 SEP 2003, DOI: 10.1002/ijc.11499

  8. You have free access to this content
    Physiologically Motivated Time-Delay Model to Account for Mechanisms Underlying Enterohepatic Circulation of Piroxicam in Human Beings

    Basic & Clinical Pharmacology & Toxicology

    Volume 104, Issue 1, January 2009, Pages: 35–42, Martina Tvrdonova, Ladislav Dedik, Constantin Mircioiu, Daniela Miklovicova and Maria Durisova

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1742-7843.2008.00304.x

  9. Wound-healing evaluation of entrapped active agents into protein microspheres over cellulosic gauzes

    Biotechnology Journal

    Volume 7, Issue 11, November 2012, Pages: 1376–1385, Raquel Silva, Helena Ferreira, Teresa Matamá, Andreia C. Gomes and Prof. Artur Cavaco-Paulo

    Version of Record online : 1 AUG 2012, DOI: 10.1002/biot.201200142

  10. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam

    Veterinary and Comparative Oncology

    L. R. Eichstadt, G. E. Moore and M. O. Childress

    Version of Record online : 6 OCT 2016, DOI: 10.1111/vco.12276

  11. Formulation and evaluation of sublingual delivery of piroxicam using thermosensitive polymer with an inverted Franz diffusion cell

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 1, January 2016, Pages: 26–35, Arunprasad Sivaraman and Ajay K. Banga

    Version of Record online : 29 DEC 2015, DOI: 10.1111/jphp.12493

  12. You have free access to this content
    A pharmacokinetic study of piroxicam in children

    Anaesthesia

    Volume 59, Issue 10, October 2004, Pages: 984–987, P. Dix, D. P. Prosser and P. Streete

    Version of Record online : 16 SEP 2004, DOI: 10.1111/j.1365-2044.2004.03806.x

  13. Crystallization of Piroxicam Solid Forms and the Effects of Additives

    Chemical Engineering & Technology

    Volume 37, Issue 8, August, 2014, Pages: 1297–1304, Guangpu Liu, Thomas B. Hansen, Haiyan Qu, Mingshi Yang, Jari P. Pajander, Jukka Rantanen and Lars P. Christensen

    Version of Record online : 9 JUL 2014, DOI: 10.1002/ceat.201400206

  14. Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 28, Issue 5, October 2005, Pages: 447–452, H. L. HEEB, R. CHUN, D. E. KOCH, L. MOORE, M. RADLINSKY, M. CORSE, M. A. PELLERIN, L. GARRETT and R. P. HUNTER

    Version of Record online : 5 OCT 2005, DOI: 10.1111/j.1365-2885.2005.00682.x

  15. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours

    Veterinary and Comparative Oncology

    Volume 9, Issue 3, September 2011, Pages: 161–171, K. Sonzogni-Desautels, D. W. Knapp, E. Sartin and M. Doré

    Version of Record online : 26 AUG 2010, DOI: 10.1111/j.1476-5829.2010.00242.x

  16. You have full text access to this Open Access content
    Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 1, January/February 2015, Pages: 261–267, S.D. Allstadt, C.O. Rodriguez Jr, B. Boostrom, R.B. Rebhun and K.A. Skorupski

    Version of Record online : 25 JAN 2015, DOI: 10.1111/jvim.12533

  17. You have free access to this content
    The in vitro effects of piroxicam and meloxicam on canine cell lines

    Journal of Small Animal Practice

    Volume 47, Issue 1, January 2006, Pages: 14–20, C. Knottenbelt, G. Chambers, E. Gault and D. J. Argyle

    Version of Record online : 16 JAN 2006, DOI: 10.1111/j.1748-5827.2006.00006.x

  18. Involvement of inflammation in severe post-operative pain demonstrated by pre-surgical and post-surgical treatment with piroxicam and ketorolac

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 5, May 2012, Pages: 747–755, Isami Fujita, Takako Okumura, Ayano Sakakibara and Yasuhiro Kita

    Version of Record online : 21 FEB 2012, DOI: 10.1111/j.2042-7158.2012.01468.x

  19. Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 4, October 2005, Pages: 362–369, Jamila A. Perini, Rosane Vianna-Jorge, Ariane R. Brogliato and Guilherme Suarez-Kurtz

    Version of Record online : 5 OCT 2005, DOI: 10.1016/j.clpt.2005.06.014

  20. You have free access to this content
    Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)

    Intervention Review

    The Cochrane Library

    Féline PB Kroon, Lennart RA van der Burg, Sofia Ramiro, Robert BM Landewé, Rachelle Buchbinder, Louise Falzon and Désirée van der Heijde

    Published Online : 17 JUL 2015, DOI: 10.1002/14651858.CD010952.pub2